Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis

Affiliations

Siyu Liu: National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., China State Institute of Pharmaceutical Industry Co. Ltd., Shanghai, People's Republic of China
Yanting Pang: National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., China State Institute of Pharmaceutical Industry Co. Ltd., Shanghai, People's Republic of China
Zeng Zhao: National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., China State Institute of Pharmaceutical Industry Co. Ltd., Shanghai, People's Republic of China
Qingyan Sun: National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., China State Institute of Pharmaceutical Industry Co. Ltd., Shanghai, People's Republic of China

Abstract

No abstracts available.

ISSN: 2628-5088 (Print); 2628-5096 (Online)
Publisher: Georg Thieme Verlag KG
Country of publisher: Germany
LCC subjects: Medicine: Pharmacy and materia medica
Website: https://www.thieme.com/books-main/chemistry/product/5416-pharmaceutical-fronts